Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies. (2021). SKIN The Journal of Cutaneous Medicine, 5(6), s51. https://doi.org/10.25251/skin.5.supp.51